TheProductLawyers.com recently outlined the sizable similarities between Xarelto and Pradaxa lawsuits, which have provided some hope to Xarelto lawsuit plaintiffs as they await future court dates. Xarelto lawsuit cases are currently still increasing in number, and cases have been consolidated in both Louisiana and Pennsylvania. The U.S. Judicial Panel on Multidistrict Litigation created MDL No. 2592, which was appointed to U.S. District Judge Eldon E. Fallon of Eastern Louisiana, and contains over 2,800 cases.
Louisiana MDL plaintiffs have claimed that in August of 2015, the MDL grew by an estimated 400 cases. Additionally, in Philadelphia, Pennsylvania, another group of cases has been consolidated by the Court of Common Pleas and has since led to the formation of a mass tort program, handling more than 550 cases and pushing the total number of Xarelto lawsuit cases to over 3,500 cases.
All plaintiffs, whether in Pennsylvania or Louisiana have named manufacturers Bayer AG and Johnson and Johnson subdivision: Janssen Pharmaceuticals as defendants, often allegedly claiming negligence by the 2 pharmaceutical giants. Judge Fallon required that 40 bellwether cases be selected by January 11th, 2016, to form a bellwether pool of cases from which the 4 bellwether cases will be chosen.
The 4 final cases will be chosen for bellwether trials in the Spring of 2017, in the hopes of expediting the process of future lawsuits and settlements. One of the most common allegations presented by plaintiffs is that the anticoagulant drug can cause unexpected, uncontrollable bleeding episodes.
Xarelto lawsuit cases are currently displaying striking parallels to blood thinner Pradaxa, which was released to the public in 2010 by manufacturer Boehringer Ingelheim. Similarly to the recent allegations against Xarelto, shortly after Pradaxa was introduced to the market it was named in over 3,500 adverse event reports, which included over 750 fatalities. Eventually, Pradaxa became the topic of over 4,000 lawsuits. Just prior to the scheduled start of the Pradaxa trials, the manufacturer settled all cases and paid $650 million to plaintiffs. Many Xarelto plaintiffs are currently hoping for settlement talks, often citing the Pradaxa settlement as an example of what could be a possibility for them.
The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-478-9711.
###
Contact TheProductLawyers.com:
Banville Law
888-478-9711
info@banvillelaw.com
165 West End Ave #1h, New York, NY 10023
